Precision Biosciences IPO Window Wide Open for Dx, Genomics Companies Premium Industry experts say a receptive market and investor interest in new technologies have spurred the increase in genomics tools and molecular diagnostics IPOs. Genome Editing Firm Precision BioSciences Prices $126.4M IPO The company plans to sell 7.9 million shares of common stock at $16 per share through its initial public offering. Pressure Biosciences Expands Sales, Marketing The company has contracted with EKG Sales Associates for life science lead generation and hired two new sales directors. Precision BioSciences Raises $25.6M in Series A Financing The North Carolina-based firm plans to use the money to continue development of its Arcus genome editing platform. Precision Bio, Nova Synthetix to Collaborate on Ricin-Free Castor Plant Development NEW YORK (GenomeWeb News) – Precision BioSciences and Nova Synthetix today announced a deal for the use of each other's technologies to generate "non-GM," ricin-free castor plants. Mar 10, 2014 Precision BioSciences, Agrivida Ink Feedstock Trait Genetic Modification Pact Jan 31, 2014 Precision BioSciences, Cellectis Settle Genome Engineering IP Dispute Jun 5, 2013 Precision BioSciences Sues Lonza for Patent Infringement May 6, 2013 Precision Bio Wins Patent Infringement Lawsuit Filed by Cellectis Nov 9, 2012 In Brief This Week: Illumina; Thermo Fisher Scientific; Accler8; Precision BioSciences, Cellectis; BG Medicine; More Apr 27, 2012 In Brief This Week: Life Technologies; LifeCodexx; Luminex; Quanterix; Precision BioSciences, Cellectis; Ocimum Biosolutions; BGI, Aspera; IDBS, ChemAxon, Thomson Reuters; Genome Designs, SciDM Group Apr 6, 2012 In Brief This Week: Bruker, SkyScan; Idaho Technology, DiaMondial; Genetic Signatures; Life Technologies; Waters; Precision BioSciences Mar 30, 2012 In Brief This Week: Ariosa Diagnostics; Abbott; Quidel; Precision BioSciences, Cellectis; Vermillion; Rosetta Genomics; BGI; NeoGenomics; Warnex; ClearBridge BioMedics Mar 16, 2012 In Brief This Week: AB Sciex; Enzo Biochem; Sigma-Aldrich; Precision BioSciences, Cellectis; Quidel; Galapagos, AstraZeneca; Cartagenia Mar 6, 2012 Precision BioSciences Files Fifth Patent Lawsuit Against Cellectis Feb 28, 2012 Precision BioSciences Files Fourth Patent Lawsuit Against Cellectis Feb 21, 2012 Precision BioSciences Files More Lawsuits Against Cellectis Alleging Patent Infringement Jan 30, 2012 In Brief This Week: Life Technologies; GenMark Diagnostics; Precision BioSciences, Cellectis; Children's Hospital Boston Jan 20, 2012 In Brief This Week: Complete Genomics; MOgene, Fluidigm; Roka Bioscience; Silicon Kinetics; Precision Biosciences; IDBS Oct 4, 2011 Cellectis, Precision Biosciences File Suits Against Each Other Again Dec 16, 2010 Precision Biosciences Receives $3M to Further Develop Genetic Engineering Technology Oct 28, 2010 Precision Bio Says USPTO Issues Final Claims Rejecting Infringement Allegations by Cellectis Sep 7, 2010 Precision Bio Says Federal Court Stays IP Litigation by Cellectis Apr 9, 2010 Precision Bio, Bayer CropScience Extend Pact Mar 8, 2010 Precision Bio Says USPTO Rejects Claims in Cellectis Patents Load More Breaking News MDxHealth, University of Oxford to Assess Prostate Test for Predicting Localized Treatment Outcomes Eagle Genomics Raises £3M in Add-On Financing Golden Helix Wins $400K SBIR Grant to Integrate Pharmacogenetics Analytics Into Genetic Testing SARS-CoV-2 Mutational Signature Associated With Mutagenic Antiviral Drug Biocartis Restructures Balance Sheet as H1 2023 Revenues Rise 12 Percent The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.